Becton, Dickinson and CompanyBDX

$143.98+2.37 (+1.67%)
NYSEHealthcareDividend King24:00 UTC

Company snapshot

Market Cap
$40B
Large-cap
+44%
2016 — today
10-Year Price
+11%
2016 — today
52-Week Range
$133.43$185.39
Current $143.98· 20%

BD (Becton, Dickinson and Company) develops, manufactures, and distributes medical technology globally. Founded in 1897, it operates through three segments: BD Medical provides medication management, IV access, injection equipment, and diabetes care. BD Life Sciences offers diagnostic and research tools, including specimen collection, microbiology automation, and cell analysis systems. BD Interventional supplies surgical instrumentation, hernia repair products, and urology and critical care devices.

Valuation in context

P/E ratio
36.5
Around average
Around the 10-year average
P/B ratio
1.7
Near historic low
Near historic low — last 10 years
EV / EBITDA
12.1
Near historic low
Near historic low — last 10 years
Dividend Yield
2.6%
Near historic high
Near historic highs — last 10 years
FCF Yield
7.8%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when BDX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.